Skip to content

LPE Blog

Big Pharma’s Get-Out-of-U.S.-Tax-Free Card

While many industries excel at not paying U.S. corporate taxes, the pharmaceutical industry takes the cake – despite $400 billion in prescription drug sales in 2022, Big Pharma claimed to have close to zero taxable income. One of their principal methods for maintaining this charade is the constant threat of exit, moving their headquarters abroad to. . .

Weekly Roundup: Jan 30

Edie Conekin-Tooze on hidden foster care as neoliberal family governance, an open letter from seventy-two UMN law faculty, and Luke Farrell on the means-testing industrial complex. Plus, Aslı Bâli and Aziz Rana on the roots of the Trump Doctrine, Sandeep Vaheesan and Brian Callaci on building democratic state capacity, Luke Herrine on the institutional foundations. . .

Weekly Roundup: Jan 23

Nathan Yaffe on the immigration agencies openly defying federal courts, and Sabeel Rahman and Jocelyn Simonson on the Part IV problem in legal scholarship. Plus, Michael Macher traces the bipartisan origins of Trump’s immigration crackdown; Eric Blanc, Claire Sandberg, and Wes McEnany advocate targeting ICE’s corporate collaborators; David Austin. . .

Game Over: The End of Financial Regulation as We Knew It

Many on the left continue to view cryptocurrency as little more than a grift. Yet the crypto industry aims to achieve something much more dangerous: functional monetary sovereignty. Their infrastructures create new conditions for exchange, wealth, and information. By ignoring these developments, we increasingly live in a dystopian world of monetary fiefdoms,. . .

Inside the Failure to Regulate Stablecoins

From legislative paralysis to regulatory fragmentation to strategic incoherence, Democrats have spent the past five years squandering opportunities to assert control over the future of digital currencies. To reverse course, progressives need to embrace a coordinated approach that balances innovation, privacy, and systemic risk.

Weekly Roundup: Dec 20

Rohan Grey and Amanda Parsons on the law and political economy of cryptocurrency, Sandeep Vaheesan on antitrust reform as an instrument for democratizing economic life, Zohra Ahmed and Madiha Tahir on the Trump administration’s escalation against Venezuela, and Quinn Slobodian on the dim prospects of centrist post-neoliberalism. Plus, a “freedom from. . .

Beginning with Empire

U.S. attacks on alleged drug trafficking boats in the Caribbean have been widely condemned for violating international law. Yet much of this criticism, by focusing narrowly on the Trump administration’s military excesses, risks repeating a familiar mistake: debating how the United States wages war while leaving unquestioned why it wages it at all.. . .

Why Antitrust Reform Matters

In the recent exchange between the Marxists and the antitrusters, much of the disagreement has turned on different understandings of the project of antitrust reform. What is its animating goal? Is antitrust a substitute or complement to other forms of regulation? And how does antitrust relate to broader political movements? Identifying rival stances that. . .